ISSN: 1747-4124

Journal Home

Journal Guideline

Expert Review of Gastroenterology and Hepatology Q2 Unclaimed

Taylor and Francis Ltd. United Kingdom

Unfortunately this journal has not been claimed yet. For this reason, some information may be unavailable.

Expert Review of Gastroenterology and Hepatology is a journal indexed in SJR in Gastroenterology and Hepatology with an H index of 73. It has a price of 2083 €. It has an SJR impact factor of 1,045 and it has a best quartile of Q2. It has an SJR impact factor of 1,045.

Type: Journal

Type of Copyright:

Languages:

Open Access Policy:

Type of publications:

Publication frecuency: -

Categories: Gastroenterology (Q2) Hepatology (Q2)

Price

2083 €

Inmediate OA

NPD

Embargoed OA

0 €

Non OA

Metrics

Expert Review of Gastroenterology and Hepatology

1,045

SJR Impact factor

73

H Index

75

Total Docs (Last Year)

357

Total Docs (3 years)

6111

Total Refs

1208

Total Cites (3 years)

336

Citable Docs (3 years)

2.48

Cites/Doc (2 years)

81.48

Ref/Doc

Comments

No comments ... Be the first to comment!

Publication speed *

Review quality *

Edition and editorial team *

Institutional email or ORCID *

* The email or ORCID field is only to validate the authenticity of the comment, the identity will not be public. .

Other journals with similar parameters

Frontline Gastroenterology Q2
Intestinal Research Q2
Colorectal Disease Q2
Digestive Diseases and Sciences Q2
Journal of Clinical Gastroenterology Q2

Compare this journals

Aims and Scope

Best articles by citations

Non-endoscopic biopsy techniques: a review

Targeting opioid signaling in Crohn's disease: new therapeutic pathways

Faldaprevir for the treatment of genotype-1 hepatitis C virus

Rifaximin for the treatment of hepatic encephalopathy

Novel avenues in immunotherapies for colorectal cancer

Constipation assessment scales in adults: a literature review including the new Bowel Function Index

Chronic diarrhea caused by idiopathic bile acid malabsorption: an explanation at last

Colonoscopy: is it as effective as an advanced diagnostic tool for colorectal cancer screening?

Anti-TNF levels and anti-drug antibodies, immunosuppressants and clinical outcomes in inflammatory bowel disease

Novel surgical options for gastroesophageal reflux disease

An evaluation of entecavir for the treatment of chronic hepatitis B infection in adults

Rising incidence and demographics of hepatocellular carcinoma in the USA: what does it mean?

SHOW MORE ARTICLES

Helicobacter pyloriand its effect on innate and adaptive immunity: new insights and vaccination strategies

Achieving sustained virological response: what's the impact on further hepatitis C virus-related disease?

Determinants of quality of care and treatment initiation in Medicare disabled patients with chronic hepatitis C

Factors associated with changes in self-reported health status in infliximab-treated inflammatory bowel disease patients: results from a case management survey

Biliary atresia: how medical complications and therapies impact outcome

Multidisciplinary treatment of resectable rectal cancer

The validity of suspected blood indicator software in capsule endoscopy: a systematic review and meta-analysis

The management of autoimmunity in patients with cholestatic liver diseases

Advances in radiotherapy delivery for rectal cancer: a European perspective

Esomeprazole for the treatment of peptic ulcer bleeding

Hepatitis C virus infection in patients with HIV-1: epidemiology, natural history and management

Multidrug resistance in hepatic cancer stem cells: the emerging role of miRNAs